Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.

Low sortilin tied to worse metabolic outcomes in type 2 diabetes mellitus

3 days ago
The current blood glucose monitor requires a disposable test strip and a small drop of blood.

In patients with newly diagnosed type 2 diabetes mellitus (T2DM), suppressed levels of circulating sortilin are linked to worse metabolic profiles, a new study has found.

The study included 150 participants, of whom 75 (mean age, 50.62±8.81 years; 38 females) had newly diagnosed T2DM and the remaining 75 (mean age, 51.50±9.02 years; 37 females) had normal glucose tolerance (NGT). Enzyme-linked immunosorbent assays were used to measure circulating levels of sortilin. Metabolic parameters, such as insulin resistance and lipid profile, were set as study outcomes.

Sortilin was significantly lower in the T2DM patients than in controls (138.44±38.39 vs 184.93±49.67 pg/mL; p<0.001). The difference in concentration between diabetics with vs without metabolic syndrome was not statistically significant (136.57±37.23 vs 140.47±40.04 pg/mL; p=0.663).

Insulin resistance, as indicated by the homeostasis model assessment of insulin resistance (HOMA-IR), was greater in diabetics.

Pearson’s correlation analysis found that circulating sortilin levels were significantly and negatively associated with insulin resistance, insulin concentration, fasting blood glucose, total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglyceride concentrations in diabetics only.

Multiple linear regression analysis further confirmed the inverse relationship between sortilin and HOMA-IR (β, –2.123; p=0.021), LDL-C (β, –1.976; p=0.033) and triglycerides (β, –2.014; p=0.039). High-density lipoprotein cholesterol, on the other hand, emerged as a factor positively correlated with sortilin (β, 0.875; p=0.044).

“[W]e found that reduced the circulating levels of sortilin was associated with insulin resistance and unfavourable lipid profiles in subjects with newly diagnosed T2DM,” said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 3 days ago
Metabolic and bariatric surgery (MBS) leads to large and sustained reductions in, and even reversal of, multiple risk factors for future joint disease in adolescents with severe obesity and musculoskeletal pain, according to data from the Teen Longitudinal Assessment of Bariatric Surgery study.
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 6 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.